Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
Status:
Unknown status
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether interferon-alpha is effective in prevention
of tumor recurrence for the patients with a low miR-26 expression in tumor after curative
resection of hepatocellular carcinoma.